Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
Holding ADPT?
Track your performance easily

Adaptive Biotechnologies (ADPT) Financial Statements

855 Followers

Adaptive Biotechnologies Financial Overview

Adaptive Biotechnologies's market cap is currently ―. The company's EPS TTM is $-1.466; its P/E ratio is -3.97; Adaptive Biotechnologies is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 46.44M$ 43.19M$ 41.87M$ 45.78M$ 37.92M
Gross Profit$ 29.77M$ 23.87M$ 23.82M$ 26.17M$ 18.57M
EBIT$ -29.16M$ -43.55M$ -44.54M$ -66.45M$ -46.67M
EBITDA$ -24.57M$ -35.91M$ -41.97M$ -61.06M$ -40.91M
Net Income Common Stockholders$ -32.07M$ -46.22M$ -47.51M$ -69.44M$ -50.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 243.33M$ 291.88M$ 308.87M$ 346.40M$ 371.13M
Total Assets$ 558.51M$ 584.87M$ 620.32M$ 661.13M$ 717.68M
Total Debt$ 224.53M$ 226.26M$ 228.04M$ 229.43M$ 231.23M
Net Debt$ -18.80M$ -65.62M$ -80.83M$ -116.97M$ -139.90M
Total Liabilities$ 334.93M$ 343.44M$ 345.56M$ 352.86M$ 356.05M
Stockholders Equity$ 223.77M$ 241.60M$ 274.91M$ 308.40M$ 361.73M
Cash Flow-
Free Cash Flow$ -27.41M$ -19.03M$ -39.86M$ -28.23M$ -49.46M
Operating Cash Flow$ -27.07M$ -17.30M$ -38.35M$ -26.93M$ -46.68M
Investing Cash Flow$ 5.29M$ 5.88M$ 44.51M$ 3.21M$ 26.14M
Financing Cash Flow$ 40.00K$ 30.00K$ 44.00K$ 87.00K$ 17.00K
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Adaptive Biotechnologies Debt to Assets

Adaptive Biotechnologies Cash Flow

Adaptive Biotechnologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis